DT
HealthMore in Health→
Low-dose endoxifen shows breast density reductions with fewer side effects in prevention study
Key Takeaways
- In a six-month study of 240 healthy premenopausal women, 1 mg and 2 mg daily endoxifen both reduced mammographic breast density versus placebo.
- Average density reductions were 19% at 1 mg and 26% at 2 mg, compared with prior data showing about 18.5% reduction with 20 mg tamoxifen.
- The higher 2 mg dose was associated with more hot flashes and night sweats than the lower-dose group.
DE
DT Editorial Team··via medicalxpress.com